These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27639361)
1. Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists. Zhang HK; Eaton JB; Fedolak A; Gunosewoyo H; Onajole OK; Brunner D; Lukas RJ; Yu LF; Kozikowski AP Eur J Med Chem; 2016 Nov; 124():689-697. PubMed ID: 27639361 [TBL] [Abstract][Full Text] [Related]
2. Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II. Yu LF; Eaton JB; Fedolak A; Zhang HK; Hanania T; Brunner D; Lukas RJ; Kozikowski AP J Med Chem; 2012 Nov; 55(22):9998-10009. PubMed ID: 23092294 [TBL] [Abstract][Full Text] [Related]
3. Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Zhang H; Tückmantel W; Eaton JB; Yuen PW; Yu LF; Bajjuri KM; Fedolak A; Wang D; Ghavami A; Caldarone B; Paterson NE; Lowe DA; Brunner D; Lukas RJ; Kozikowski AP J Med Chem; 2012 Jan; 55(2):717-24. PubMed ID: 22171543 [TBL] [Abstract][Full Text] [Related]
4. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist. Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors. Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors. Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part III. Onajole OK; Vallerini GP; Eaton JB; Lukas RJ; Brunner D; Caldarone BJ; Kozikowski AP ACS Chem Neurosci; 2016 Jun; 7(6):811-22. PubMed ID: 27035276 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists. Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists. Carroll FI; Ma W; Deng L; Navarro HA; Damaj MI; Martin BR J Nat Prod; 2010 Mar; 73(3):306-12. PubMed ID: 20038125 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates. Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805 [TBL] [Abstract][Full Text] [Related]
16. Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts. Crestey F; Jensen AA; Soerensen C; Magnus CB; Andreasen JT; Peters GHJ; Kristensen JL J Med Chem; 2018 Feb; 61(4):1719-1729. PubMed ID: 29384668 [TBL] [Abstract][Full Text] [Related]
17. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs. Eibl C; Munoz L; Tomassoli I; Stokes C; Papke RL; Gündisch D Bioorg Med Chem; 2013 Dec; 21(23):7309-29. PubMed ID: 24145137 [TBL] [Abstract][Full Text] [Related]
18. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them. Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity. Yu LF; Tückmantel W; Eaton JB; Caldarone B; Fedolak A; Hanania T; Brunner D; Lukas RJ; Kozikowski AP J Med Chem; 2012 Jan; 55(2):812-23. PubMed ID: 22148173 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]